GlassScriptPhysician profile
Corinna Ann Cooper
NPI 1366542334
$6,109.90
in general payments reported to CMS, 2019-2025
19 companies · $5,196 in 2025
The $5,196 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $218 · 2021: $142 · 2022: $131 · 2023: $126 · 2024: $113 · 2025: $5,196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Travel and Lodging: $2,042 · Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Travel and Lodging | $2,041.94 |
| Food and Beverage | $392.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $3,167.76 | 2023-2025 | Gelpoint V-Path |
| Intuitive Surgical, INC. | $1,917.64 | 2025 | |
| Abbvie INC. | $356.95 | 2019-2022 | |
| Daiichi Sankyo INC. | $109.10 | 2019-2022 | |
| Astellas Pharma US INC | $90.44 | 2024-2025 | Veozah |
| Biogen, INC. | $76.38 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $62.25 | 2023-2025 | Thinprep 2000 Processor, Aptima, Acessa Provu System |
| Evofem Biosciences, INC. | $47.14 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.37 | 2020 | |
| Exeltis, USA INC. | $44.58 | 2022-2023 | Slynd |
| Organon LLC | $38.21 | 2022-2024 | Nexplanon |
| Sumitomo Pharma America, INC. | $34.62 | 2023-2024 | Myfembree |
| Avion Pharmaceuticals | $26.24 | 2020-2021 | |
| Agile Therapeutics, INC. | $20.73 | 2021 | |
| Covidien LP | $17.14 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $14.26 | 2024 | |
| Sanofi Pasteur INC. | $13.93 | 2025 | |
| Amag Pharmaceuticals, INC. | $13.15 | 2019 | |
| Coopersurgical, INC. | $13.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corinna Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.